statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics, Inc. (NASDAQ:MRSN  Get Free Report)s share price gapped up before the market opened on Tuesday . The stock had previously closed at $4.86, but opened at $4.99...

Mersana Therapeutics (NASDAQ:MRSN) Shares Gap Up to $4.86

Latest Ratings for MRSN
 DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Aug 2021HC Wainwright & Co.Initiates Coverage OnBuy Mar 2021Credit SuisseInitiates Coverage OnNeutral
 View...

The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts

This is a signal that MRSN's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Mersana Therapeutics (MRSN, $5.01) Stochastic Oscillator left the oversold zone on March 15, 2024

MRSN's total volume now sits at 2.2M. The +0.70% price change was insignificant, leaving IBM's price at $5.04...

The volume for Mersana Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 200% of the 65-Day Volume Moving Average

This is a signal that MRSN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Mersana Therapeutics (MRSN, $5.01) RSI Indicator left the overbought zone on March 14, 2024

This is a Bearish indicator signaling MRSN's price could decline from here. Traders may explore shorting the stock or put options...

Mersana Therapeutics (MRSN, $5.01) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 14, 2024

This indicator may be signaling that MRSN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Mersana Therapeutics (MRSN, $5.01) entered Downtrend as Momentum indicator drops below 0 level on Mar 14, 2024

Investors considering a purchase of Mersana Therapeutics Inc (MRSN) shares, but tentative about paying the going market price of 5.83/share, might benefit from considering selling puts among the...

Commit To Purchase Mersana Therapeutics At $3, Earn 25.5% Annualized Using Options

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN  Get Free Report) have received an average recommendation of Moderate Buy from the seven ratings firms that are currently...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Average Recommendation of "Moderate Buy" from Analysts

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Volume	1.19M
52-Wk High	$9.62
52-Wk Low	$0.8014

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.18	--	--	N/A
Q4'23	-$0.16	-$0.16	-1.97%	MISSED
Q3'23	-$0.36	-$0.35	2.18%	BEAT
Q2'23	-$0.44	-$0.47	-7.70%	MISSED
Q1'23	-$0.43	-$0.52	-21.50%	MISSED

MRSN Mersana Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals